Real‐world data prognostic model of overall survival in patients with advanced NSCLC receiving anti‐PD‐1/PD‐L1 immune checkpoint inhibitors as second‐line monotherapy

Abstract Background and aim The objective of this retrospective, observational, noninterventional cohort study was to investigate prognostic factors of overall survival (OS) in patients with advanced non‐small cell lung cancer (aNSCLC) and to develop a novel prognostic model. Methods A total of 4049...

Descripció completa

Dades bibliogràfiques

Autors principals:	Cristina Julian, Robson J. M. Machado, Sandhya Girish, Pascal Chanu, Dominik Heinzmann, Chris Harbron, Anda Gershon, Shannon M. Pfeiffer, Wei Zou, Valerie Quarmby, Qing Zhang, Yachi Chen
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2022-10-01
Col·lecció:	Cancer Reports
Matèries:	advanced NSCLC immune checkpoint inhibitors prognostic model real‐world data
Accés en línia:	https://doi.org/10.1002/cnr2.1578
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!